Trials / Sponsors / Janssen-Cilag Farmaceutica Ltda.

Janssen-Cilag Farmaceutica Ltda.

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants Metastatic Castration-resistant Prostate Cancer	—	2020-03-19
Completed	A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1 HIV	—	2019-12-17
Completed	A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resou Schizophrenia	—	2018-08-07
Completed	Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate Schizophrenia	Phase 3	2011-09-01
Completed	The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life Dementia	Phase 4	2008-06-01
No Longer Available	An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS) Myelodysplastic Syndromes	—	2008-06-01
Completed	A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperid Schizophrenia	Phase 4	2008-02-01
Completed	Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Def Attention Deficit Hyperactivity Disorder	Phase 4	2008-02-01
Completed	An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. Binge Eating	Phase 3	2003-11-01
Completed	An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of N Contraception	Phase 4	2003-02-01
Approved For Marketing	Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leuke B-cell Chronic Lymphocytic Leukemia	—	—